New Incyte bioplant opens in Switzerland
Share this article
Incyte opens its new bioplant in Yverdon-les-bains in the Canton of Vaud
On 31 August 2021, Incyte, the US-based global biopharmaceutical company, which specialises in the discovery, development and commercialisation of novel medicines, announced the opening of its new bioplant facility at Y-Parc in Yverdon-les-bains in the Canton of Vaud.
This new multi-product, high-efficiency facility consists of a 13’300 m2 campus composed of three buildings housing production, technical operations and analytical labs. The expertise on campus will reach from manufacturing, quality control, process engineering to supply chain and more.
Interview in French of Hervé Hoppenot’s (Incyte’s General Director) on “La Matinale – RTS”